nodes	percent_of_prediction	percent_of_DWPC	metapath
Budesonide—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0746	0.332	CbGbCtD
Budesonide—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0694	0.308	CbGbCtD
Budesonide—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0319	0.142	CbGbCtD
Budesonide—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0292	0.13	CbGbCtD
Budesonide—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0199	0.0885	CbGbCtD
Budesonide—Triamcinolone—BCHE—peripheral nervous system neoplasm	0.00139	0.344	CrCbGaD
Budesonide—Methylprednisolone—ABCB1—peripheral nervous system neoplasm	0.000644	0.16	CrCbGaD
Budesonide—Prednisone—ABCB1—peripheral nervous system neoplasm	0.000492	0.122	CrCbGaD
Budesonide—Prednisolone—ABCB1—peripheral nervous system neoplasm	0.000454	0.113	CrCbGaD
Budesonide—Betamethasone—ABCB1—peripheral nervous system neoplasm	0.000445	0.11	CrCbGaD
Budesonide—Nausea—Melphalan—peripheral nervous system neoplasm	0.000365	0.000473	CcSEcCtD
Budesonide—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000363	0.000471	CcSEcCtD
Budesonide—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000361	0.000468	CcSEcCtD
Budesonide—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000359	0.000466	CcSEcCtD
Budesonide—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000359	0.000466	CcSEcCtD
Budesonide—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000359	0.000466	CcSEcCtD
Budesonide—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000358	0.000465	CcSEcCtD
Budesonide—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000357	0.000464	CcSEcCtD
Budesonide—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000356	0.000461	CcSEcCtD
Budesonide—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000355	0.00046	CcSEcCtD
Budesonide—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000353	0.000458	CcSEcCtD
Budesonide—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000351	0.000455	CcSEcCtD
Budesonide—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000351	0.000455	CcSEcCtD
Budesonide—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000349	0.000453	CcSEcCtD
Budesonide—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000349	0.000453	CcSEcCtD
Budesonide—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000348	0.000451	CcSEcCtD
Budesonide—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000347	0.000451	CcSEcCtD
Budesonide—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000347	0.00045	CcSEcCtD
Budesonide—Hydrocortisone—ABCB1—peripheral nervous system neoplasm	0.000347	0.0862	CrCbGaD
Budesonide—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000347	0.00045	CcSEcCtD
Budesonide—Pain—Cisplatin—peripheral nervous system neoplasm	0.000344	0.000446	CcSEcCtD
Budesonide—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000339	0.00044	CcSEcCtD
Budesonide—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000338	0.000439	CcSEcCtD
Budesonide—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000338	0.000438	CcSEcCtD
Budesonide—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000336	0.000435	CcSEcCtD
Budesonide—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000335	0.000435	CcSEcCtD
Budesonide—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000335	0.000434	CcSEcCtD
Budesonide—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000334	0.000433	CcSEcCtD
Budesonide—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000331	0.000429	CcSEcCtD
Budesonide—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.00033	0.000429	CcSEcCtD
Budesonide—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.00033	0.000428	CcSEcCtD
Budesonide—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000328	0.000426	CcSEcCtD
Budesonide—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000327	0.000424	CcSEcCtD
Budesonide—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000326	0.000423	CcSEcCtD
Budesonide—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000323	0.00042	CcSEcCtD
Budesonide—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000323	0.00042	CcSEcCtD
Budesonide—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000323	0.000419	CcSEcCtD
Budesonide—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000323	0.000419	CcSEcCtD
Budesonide—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000323	0.000418	CcSEcCtD
Budesonide—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000321	0.000416	CcSEcCtD
Budesonide—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.00032	0.000415	CcSEcCtD
Budesonide—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000318	0.000412	CcSEcCtD
Budesonide—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000318	0.000412	CcSEcCtD
Budesonide—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000317	0.000412	CcSEcCtD
Budesonide—Pain—Etoposide—peripheral nervous system neoplasm	0.000315	0.000408	CcSEcCtD
Budesonide—Constipation—Etoposide—peripheral nervous system neoplasm	0.000315	0.000408	CcSEcCtD
Budesonide—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000314	0.000408	CcSEcCtD
Budesonide—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000314	0.000408	CcSEcCtD
Budesonide—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000314	0.000407	CcSEcCtD
Budesonide—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000312	0.000404	CcSEcCtD
Budesonide—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000311	0.000403	CcSEcCtD
Budesonide—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.00031	0.000402	CcSEcCtD
Budesonide—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000308	0.0004	CcSEcCtD
Budesonide—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000305	0.000396	CcSEcCtD
Budesonide—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000305	0.000396	CcSEcCtD
Budesonide—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000303	0.000394	CcSEcCtD
Budesonide—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000303	0.000393	CcSEcCtD
Budesonide—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000302	0.000392	CcSEcCtD
Budesonide—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000301	0.00039	CcSEcCtD
Budesonide—Dizziness—Vincristine—peripheral nervous system neoplasm	0.0003	0.00039	CcSEcCtD
Budesonide—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.0003	0.000389	CcSEcCtD
Budesonide—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000299	0.000388	CcSEcCtD
Budesonide—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000299	0.000388	CcSEcCtD
Budesonide—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000297	0.000386	CcSEcCtD
Budesonide—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000297	0.000385	CcSEcCtD
Budesonide—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000296	0.000384	CcSEcCtD
Budesonide—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000295	0.000383	CcSEcCtD
Budesonide—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000292	0.000379	CcSEcCtD
Budesonide—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000292	0.000379	CcSEcCtD
Budesonide—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000291	0.000378	CcSEcCtD
Budesonide—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000291	0.000377	CcSEcCtD
Budesonide—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000291	0.000377	CcSEcCtD
Budesonide—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000291	0.000377	CcSEcCtD
Budesonide—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000291	0.000377	CcSEcCtD
Budesonide—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.00029	0.000377	CcSEcCtD
Budesonide—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000289	0.000375	CcSEcCtD
Budesonide—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000288	0.000374	CcSEcCtD
Budesonide—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000288	0.000374	CcSEcCtD
Budesonide—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000287	0.000372	CcSEcCtD
Budesonide—Rash—Vincristine—peripheral nervous system neoplasm	0.000286	0.000372	CcSEcCtD
Budesonide—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000286	0.000371	CcSEcCtD
Budesonide—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000286	0.000371	CcSEcCtD
Budesonide—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000285	0.00037	CcSEcCtD
Budesonide—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000285	0.00037	CcSEcCtD
Budesonide—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000285	0.000369	CcSEcCtD
Budesonide—Headache—Vincristine—peripheral nervous system neoplasm	0.000285	0.000369	CcSEcCtD
Budesonide—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000282	0.000366	CcSEcCtD
Budesonide—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000281	0.000364	CcSEcCtD
Budesonide—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00028	0.000363	CcSEcCtD
Budesonide—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.00028	0.000363	CcSEcCtD
Budesonide—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000275	0.000356	CcSEcCtD
Budesonide—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000271	0.000352	CcSEcCtD
Budesonide—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000271	0.000352	CcSEcCtD
Budesonide—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.00027	0.00035	CcSEcCtD
Budesonide—Nausea—Vincristine—peripheral nervous system neoplasm	0.00027	0.00035	CcSEcCtD
Budesonide—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000269	0.00035	CcSEcCtD
Budesonide—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000269	0.00035	CcSEcCtD
Budesonide—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000269	0.000349	CcSEcCtD
Budesonide—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000269	0.000348	CcSEcCtD
Budesonide—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000267	0.000346	CcSEcCtD
Budesonide—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000265	0.000344	CcSEcCtD
Budesonide—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000265	0.000343	CcSEcCtD
Budesonide—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000264	0.000342	CcSEcCtD
Budesonide—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000264	0.000342	CcSEcCtD
Budesonide—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000263	0.000342	CcSEcCtD
Budesonide—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000263	0.000342	CcSEcCtD
Budesonide—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000262	0.00034	CcSEcCtD
Budesonide—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000262	0.000339	CcSEcCtD
Budesonide—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00026	0.000338	CcSEcCtD
Budesonide—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000259	0.000336	CcSEcCtD
Budesonide—Dexamethasone—ABCB1—peripheral nervous system neoplasm	0.000259	0.0642	CrCbGaD
Budesonide—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000257	0.000333	CcSEcCtD
Budesonide—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000255	0.000331	CcSEcCtD
Budesonide—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000254	0.00033	CcSEcCtD
Budesonide—Rash—Cisplatin—peripheral nervous system neoplasm	0.000253	0.000329	CcSEcCtD
Budesonide—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000253	0.000328	CcSEcCtD
Budesonide—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000253	0.000328	CcSEcCtD
Budesonide—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000252	0.000327	CcSEcCtD
Budesonide—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000251	0.000326	CcSEcCtD
Budesonide—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000249	0.000323	CcSEcCtD
Budesonide—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000249	0.000323	CcSEcCtD
Budesonide—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000249	0.000323	CcSEcCtD
Budesonide—Tension—Epirubicin—peripheral nervous system neoplasm	0.000248	0.000322	CcSEcCtD
Budesonide—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000248	0.000321	CcSEcCtD
Budesonide—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000246	0.000318	CcSEcCtD
Budesonide—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000245	0.000317	CcSEcCtD
Budesonide—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000244	0.000316	CcSEcCtD
Budesonide—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000243	0.000316	CcSEcCtD
Budesonide—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000243	0.000315	CcSEcCtD
Budesonide—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000243	0.000315	CcSEcCtD
Budesonide—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000242	0.000314	CcSEcCtD
Budesonide—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000239	0.000309	CcSEcCtD
Budesonide—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000238	0.000309	CcSEcCtD
Budesonide—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000237	0.000308	CcSEcCtD
Budesonide—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.000305	CcSEcCtD
Budesonide—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000235	0.000304	CcSEcCtD
Budesonide—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000234	0.000303	CcSEcCtD
Budesonide—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.000303	CcSEcCtD
Budesonide—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000234	0.000303	CcSEcCtD
Budesonide—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000232	0.000301	CcSEcCtD
Budesonide—Rash—Etoposide—peripheral nervous system neoplasm	0.000232	0.000301	CcSEcCtD
Budesonide—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000232	0.000301	CcSEcCtD
Budesonide—Headache—Etoposide—peripheral nervous system neoplasm	0.000231	0.000299	CcSEcCtD
Budesonide—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.00023	0.000299	CcSEcCtD
Budesonide—Tension—Doxorubicin—peripheral nervous system neoplasm	0.00023	0.000298	CcSEcCtD
Budesonide—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000229	0.000297	CcSEcCtD
Budesonide—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000228	0.000296	CcSEcCtD
Budesonide—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000227	0.000295	CcSEcCtD
Budesonide—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000227	0.000295	CcSEcCtD
Budesonide—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000227	0.000294	CcSEcCtD
Budesonide—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.000293	CcSEcCtD
Budesonide—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.000292	CcSEcCtD
Budesonide—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000223	0.00029	CcSEcCtD
Budesonide—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000222	0.000288	CcSEcCtD
Budesonide—Cough—Epirubicin—peripheral nervous system neoplasm	0.000221	0.000286	CcSEcCtD
Budesonide—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.00022	0.000286	CcSEcCtD
Budesonide—Nausea—Etoposide—peripheral nervous system neoplasm	0.000219	0.000284	CcSEcCtD
Budesonide—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000218	0.000283	CcSEcCtD
Budesonide—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000217	0.000281	CcSEcCtD
Budesonide—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.00028	CcSEcCtD
Budesonide—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000215	0.000279	CcSEcCtD
Budesonide—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000215	0.000279	CcSEcCtD
Budesonide—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000215	0.000279	CcSEcCtD
Budesonide—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.000279	CcSEcCtD
Budesonide—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000214	0.000278	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000214	0.000277	CcSEcCtD
Budesonide—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000213	0.000276	CcSEcCtD
Budesonide—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.000274	CcSEcCtD
Budesonide—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.00021	0.000273	CcSEcCtD
Budesonide—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.000273	CcSEcCtD
Budesonide—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.000272	CcSEcCtD
Budesonide—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000208	0.00027	CcSEcCtD
Budesonide—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.000268	CcSEcCtD
Budesonide—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000206	0.000268	CcSEcCtD
Budesonide—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.000267	CcSEcCtD
Budesonide—Infection—Epirubicin—peripheral nervous system neoplasm	0.000205	0.000266	CcSEcCtD
Budesonide—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000204	0.000265	CcSEcCtD
Budesonide—Shock—Epirubicin—peripheral nervous system neoplasm	0.000203	0.000263	CcSEcCtD
Budesonide—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000202	0.000262	CcSEcCtD
Budesonide—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000202	0.000262	CcSEcCtD
Budesonide—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000201	0.000261	CcSEcCtD
Budesonide—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.0002	0.00026	CcSEcCtD
Budesonide—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000199	0.000259	CcSEcCtD
Budesonide—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.000258	CcSEcCtD
Budesonide—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.000258	CcSEcCtD
Budesonide—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.000258	CcSEcCtD
Budesonide—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000198	0.000257	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000198	0.000256	CcSEcCtD
Budesonide—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000197	0.000255	CcSEcCtD
Budesonide—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000197	0.000255	CcSEcCtD
Budesonide—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.000253	CcSEcCtD
Budesonide—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000192	0.00025	CcSEcCtD
Budesonide—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000191	0.000248	CcSEcCtD
Budesonide—Infection—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.000246	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000188	0.000244	CcSEcCtD
Budesonide—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.000244	CcSEcCtD
Budesonide—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.000243	CcSEcCtD
Budesonide—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000187	0.000242	CcSEcCtD
Budesonide—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000242	CcSEcCtD
Budesonide—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000185	0.00024	CcSEcCtD
Budesonide—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000185	0.00024	CcSEcCtD
Budesonide—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000185	0.000239	CcSEcCtD
Budesonide—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000184	0.000239	CcSEcCtD
Budesonide—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000183	0.000238	CcSEcCtD
Budesonide—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000236	CcSEcCtD
Budesonide—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000182	0.000236	CcSEcCtD
Budesonide—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000179	0.000233	CcSEcCtD
Budesonide—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000178	0.000231	CcSEcCtD
Budesonide—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000178	0.000231	CcSEcCtD
Budesonide—Pain—Epirubicin—peripheral nervous system neoplasm	0.000176	0.000229	CcSEcCtD
Budesonide—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000176	0.000229	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.000226	CcSEcCtD
Budesonide—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.000224	CcSEcCtD
Budesonide—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000222	CcSEcCtD
Budesonide—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.000221	CcSEcCtD
Budesonide—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.00017	0.00022	CcSEcCtD
Budesonide—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.00022	CcSEcCtD
Budesonide—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000169	0.000219	CcSEcCtD
Budesonide—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000218	CcSEcCtD
Budesonide—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000215	CcSEcCtD
Budesonide—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000214	CcSEcCtD
Budesonide—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000213	CcSEcCtD
Budesonide—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000164	0.000213	CcSEcCtD
Budesonide—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000212	CcSEcCtD
Budesonide—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000212	CcSEcCtD
Budesonide—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000212	CcSEcCtD
Budesonide—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000212	CcSEcCtD
Budesonide—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000204	CcSEcCtD
Budesonide—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.000202	CcSEcCtD
Budesonide—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000197	CcSEcCtD
Budesonide—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000197	CcSEcCtD
Budesonide—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000196	CcSEcCtD
Budesonide—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000196	CcSEcCtD
Budesonide—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000192	CcSEcCtD
Budesonide—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000189	CcSEcCtD
Budesonide—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000141	0.000183	CcSEcCtD
Budesonide—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000182	CcSEcCtD
Budesonide—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000178	CcSEcCtD
Budesonide—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000177	CcSEcCtD
Budesonide—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000175	CcSEcCtD
Budesonide—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000131	0.00017	CcSEcCtD
Budesonide—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000169	CcSEcCtD
Budesonide—Rash—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000169	CcSEcCtD
Budesonide—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000169	CcSEcCtD
Budesonide—Headache—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000168	CcSEcCtD
Budesonide—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000164	CcSEcCtD
Budesonide—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000159	CcSEcCtD
Budesonide—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000157	CcSEcCtD
Budesonide—Rash—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000156	CcSEcCtD
Budesonide—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000156	CcSEcCtD
Budesonide—Headache—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000155	CcSEcCtD
Budesonide—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000147	CcSEcCtD
